NASDAQ:VMD - Nasdaq - CA92663R1055 - Common Stock - Currency: USD
NASDAQ:VMD (5/9/2025, 8:26:31 PM)
6.32
-0.1 (-1.56%)
The current stock price of VMD is 6.32 USD. In the past month the price decreased by -3.22%. In the past year, price decreased by -11.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.08 | 90.40B | ||
CVS | CVS HEALTH CORP | 10.53 | 84.54B | ||
LH | LABCORP HOLDINGS INC | 16.68 | 20.57B | ||
DGX | QUEST DIAGNOSTICS INC | 19.26 | 19.76B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 17.86 | 16.66B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 129.32 | 14.04B | ||
HIMS | HIMS & HERS HEALTH INC | 75.3 | 11.62B | ||
DVA | DAVITA INC | 15.13 | 11.05B | ||
CHE | CHEMED CORP | 24.19 | 8.34B | ||
CRVL | CORVEL CORP | 26.92 | 5.78B | ||
OPCH | OPTION CARE HEALTH INC | 23.41 | 5.21B | ||
GH | GUARDANT HEALTH INC | N/A | 5.17B |
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana and currently employs 1,179 full-time employees. The company went IPO on 2017-12-22. The firm focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, and other medical equipment. The company offers in-home sleep apnea testing services. The firm also provides healthcare staffing and recruitment services.
VIEMED HEALTHCARE INC
625 E. Kaliste Saloom Rd.
Lafayette LOUISIANA 70508 US
CEO: Casey Hoyt
Employees: 1179
Phone: 13375043802
The current stock price of VMD is 6.32 USD. The price decreased by -1.56% in the last trading session.
The exchange symbol of VIEMED HEALTHCARE INC is VMD and it is listed on the Nasdaq exchange.
VMD stock is listed on the Nasdaq exchange.
7 analysts have analysed VMD and the average price target is 13.09 USD. This implies a price increase of 107.12% is expected in the next year compared to the current price of 6.32. Check the VIEMED HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VIEMED HEALTHCARE INC (VMD) has a market capitalization of 249.77M USD. This makes VMD a Micro Cap stock.
VIEMED HEALTHCARE INC (VMD) currently has 1179 employees.
VIEMED HEALTHCARE INC (VMD) has a support level at 6.31 and a resistance level at 7.03. Check the full technical report for a detailed analysis of VMD support and resistance levels.
The Revenue of VIEMED HEALTHCARE INC (VMD) is expected to grow by 16.23% in the next year. Check the estimates tab for more information on the VMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VMD does not pay a dividend.
VIEMED HEALTHCARE INC (VMD) will report earnings on 2025-08-05.
The PE ratio for VIEMED HEALTHCARE INC (VMD) is 21.07. This is based on the reported non-GAAP earnings per share of 0.3 and the current share price of 6.32 USD. Check the full fundamental report for a full analysis of the valuation metrics for VMD.
The outstanding short interest for VIEMED HEALTHCARE INC (VMD) is 0.99% of its float. Check the ownership tab for more information on the VMD short interest.
ChartMill assigns a technical rating of 1 / 10 to VMD. When comparing the yearly performance of all stocks, VMD is a bad performer in the overall market: 75.52% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to VMD. Both the profitability and the financial health of VMD get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months VMD reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 15.38% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.02% | ||
ROA | 6.36% | ||
ROE | 8.57% | ||
Debt/Equity | 0.03 |
ChartMill assigns a Buy % Consensus number of 80% to VMD. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 35.27% and a revenue growth 16.23% for VMD